| Quick Answer |
| Noveltreat, Semaglyn and Samakind contain the same GLP-1 medicine, semaglutide, so the real differences sit in the pen. Sun Pharma’s Noveltreat uses a separate prefilled pen for each of five strengths. Zydus’s Semaglyn uses one reusable pen with refill cartridges. Mankind’s Samakind competes mainly on pharmacy reach. Your doctor matches the device to your dose plan. |
On 20 March 2026 the Indian patent on semaglutide expired, and by the next day the first wave of generic semaglutide in India was reaching chemists. For anyone weighing noveltreat vs semaglyn, or adding Samakind to the shortlist, the confusing part is that the medicine inside is identical.
Side-by-Side Comparison
Device and strength details below come from each maker’s launch announcements, checked in October 2026.
| Brand | Maker | Strengths | Pen type | How cost builds up | Availability |
| Noveltreat | Sun Pharma | 0.25, 0.5, 1, 1.7 and 2.4 mg, one pen per strength | Single-strength prefilled pen with a concealed needle | Changes at each step up; settles at maintenance | Launched nationally in all strengths, March 2026 |
| Semaglyn | Zydus Lifesciences (also sold as Mashema and Alterme) | All approved doses dialled from one 15 mg/3 mL cartridge | Reusable dial-a-dose pen with prefilled cartridge | Pen bought once, then cartridges; higher doses use cartridges faster | Launched March 2026; pen and cartridge listed separately online |
| Samakind | Mankind Pharma | Not detailed in public launch material; check the carton | Pen format; mechanism not published | Confirm pack and strength with your pharmacist | Day-one launch built on Mankind’s small-town chemist network |
Prices are left out because MRPs differ by strength and change often. The price section explains how each brand’s cost builds up.
Noveltreat: Overview
Noveltreat is Sun Pharma’s semaglutide for chronic weight management in adults, used alongside a lower-calorie diet and more physical activity. If you have searched for sun pharma semaglutide, this is the weight-management brand you were looking for.
Sun announced its regulatory approval in January 2026, and Sun Pharma’s approval announcement noted that the approval followed review of a Phase III trial run in India. Generic approvals usually rest on showing that the copy behaves like the original; Sun’s file also included a trial in Indian adults.
The pen comes in five fixed strengths: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg, the last being the maintenance dose. Each pen delivers one strength only, so every step up means a new pen.
Sun’s March 2026 launch statement describes a concealed needle, which helps anyone who flinches at the sight of one.
Sun also sells a sister brand, Sematrinity, with the same medicine in a multi-dose pen. Sematrinity is approved for type 2 diabetes, not weight management, so the two are not interchangeable at the chemist’s counter.
Semaglyn: Overview
Semaglyn is Zydus Lifesciences’ semaglutide, approved in India for both type 2 diabetes and obesity. Its point of difference is the device.
Instead of a separate pen for each strength, Zydus uses one reusable pen loaded with a prefilled cartridge holding 15 mg of medicine in 3 mL. You dial the dose your doctor sets, and the same pen stays with you from the starting dose to maintenance.
Think of it as a fountain pen with ink cartridges, where Noveltreat works more like a pen you finish and replace.
According to Zydus’s launch announcement, the company holds exclusive rights to the pen. The same product also reaches shelves as Mashema and Alterme, so a different name on the box does not always mean a different medicine.
Online pharmacies list the reusable pen separately from the medicine (October 2026), so the first purchase needs both.
Samakind: Overview
Samakind is Mankind Pharma’s semaglutide, launched on the day the patent lapsed. Mankind has positioned it on distribution rather than on device design.
At the time of writing, Mankind’s public launch material does not spell out the pen mechanism or the full list of strengths.
So before your first dose, read the carton and the package insert. Ask the pharmacist two things: whether the pen holds one strength or lets you dial several, and whether every step of your dose plan is available in your town.
Pen Design and Dosing Accuracy
Both pen styles can deliver accurate doses. The bigger risk sits in how a person handles the pen, not in whether it is reusable or prefilled.
Every medical injection pen is tested against an international standard (ISO 11608-1) that limits how far a dose may drift from the number on the pen.
A laboratory study, Differences in the Dose Accuracy of Insulin Pens, tested two prefilled and two reusable pens. All four met the standard on average. The surprise lay in the spread: one prefilled and one reusable pen stayed tightly on target, while the other two were less consistent.
That study used insulin, not semaglutide, but the principle travels. Accuracy belongs to a specific device and how well it is built, not to the reusable or prefilled label.
A reusable dial-a-dose pen asks more of you. You load the cartridge. You attach a fresh needle. You run the flow check the first time. You set the dose, inject, and hold the button down for the count the leaflet gives.
Older users, or anyone with weak near vision, should do the first injection with a family member watching.
Whatever the pen, the medicine is a protein and dislikes heat. Unopened pens and cartridges usually belong in the fridge, in the door or middle shelf rather than beside the freezer, but follow the storage line on your own carton. A May afternoon in a parked car in Nagpur will harm a dose faster than any design flaw.
Dose Steps Across Brands
The dose ladder is the same medicine-wise across brands: start low, step up every four weeks, then settle on a maintenance dose. What changes is how each pen climbs it.
Starting low gives the gut time to adjust. In the STEP 1 trial of 1,961 adults, the dose rose every four weeks over 16 weeks to reach 2.4 mg, and stomach complaints such as nausea were the most common side effects, mostly mild to moderate and short-lived.
| Weeks | Standard dose | Noveltreat | Semaglyn | Samakind |
| 1 to 4 | 0.25 mg | 0.25 mg pen | Dialled on same pen | Check carton |
| 5 to 8 | 0.5 mg | 0.5 mg pen | Dialled on same pen | Check carton |
| 9 to 12 | 1 mg | 1 mg pen | Dialled on same pen | Check carton |
| 13 to 16 | 1.7 mg | 1.7 mg pen | Dialled on same pen | Check carton |
| 17 onward | 2.4 mg (maintenance) | 2.4 mg pen | Dialled on same pen | Check carton |
Your doctor may hold you on a step for longer if nausea is troublesome, or stop below 2.4 mg if you are doing well lower down.
Many users notice the first few days of a new step most after a heavy dinner. A smaller, earlier evening meal, the katori of dal and two rotis rather than the full thali at ten at night, often sits easier.
Trials of this medicine have helped people lose up to 20% of their body weight, alongside diet change, activity and medical follow-up.
Price Compared
This page does not print prices, and that is a deliberate choice. Anyone searching semaglutide prices in India meets figures that change with each strength, each pharmacy and each month, and a stale number misleads more than no number.
With Semaglyn, you buy the reusable pen once, then buy cartridges. Every cartridge holds the same 15 mg, so a higher weekly dose empties it sooner. At 2.4 mg a week, one cartridge holds six full doses; at the starting dose it holds more than you can use within the period the label allows for an opened cartridge.
A fair comparison is the cost of a month at the dose your doctor expects you to stay on, counting needles and, for a reusable pen, the device itself. Ask the pharmacist for the MRP printed on each pack and work it out for that one dose.
Availability in Indian Pharmacies
No brand is guaranteed on every shelf. Stock depends on the maker’s distribution network, its cold-chain handling and how quickly a town’s chemists reorder.
Sun Pharma launched Noveltreat in all five strengths at once. Zydus sells one product under three names, so if Semaglyn is out of stock, ask your doctor whether Mashema or Alterme can be written instead.
Mankind’s reach into smaller towns is its stated advantage for Samakind. The need it serves is national: the ICMR-INDIAB national study estimated roughly 254 million Indian adults with generalised obesity and 351 million with abdominal obesity.
Buy only against a prescription, from a licensed pharmacy; semaglutide is a prescription-only medicine in India. If you order online, check that the pack is sealed and arrives with cold packs where the label asks for refrigeration. Refuse it if either check fails.
Switching Brands Mid-Treatment
Switching is possible because the medicine is the same. It should happen through your doctor, on your usual injection day, at the same milligram dose.
The device does not carry over. A Semaglyn cartridge is designed for the Zydus pen, and a Noveltreat pen cannot be refilled. Never draw medicine out of one pen to use in another.
A switch usually runs in five short steps:
| Step | What happens |
|---|---|
| 1 | Your doctor writes the new brand and the same milligram dose on a fresh prescription. |
| 2 | You take your last dose of the old brand on your usual day. |
| 3 | Before the next dose, the pharmacist or doctor shows you how the new pen works. |
| 4 | You take the first dose of the new brand seven days later, on the same weekday. |
| 5 | You note any change in nausea or appetite over the next two weeks and report it. |
Half of each dose is still circulating in the body a week after you inject it (its half-life). That is why a one-day slip during a switch rarely matters.
Missing two or more weeks is different. Your doctor may restart you on a lower step so your stomach can readjust.
Check the approved use too. Noveltreat is approved for weight management, Sematrinity for type 2 diabetes, and Semaglyn for both. A switch should keep you on a brand approved for the reason you are being treated.
Which Should You Choose?
No single brand suits everyone. The useful question is which device fits your life.
If a little setup does not bother you and you would rather learn one device for the whole climb, the reusable Semaglyn pen suits that habit.
If your nearest chemist is in a smaller town, start with what that chemist can reliably keep in stock. A brand you can buy every month beats one you have to chase.
Underneath all of this sits a clinical decision. The 2025 revised definition of obesity for Asian Indians treats a BMI above 23 as obesity, replacing older guidance that called 23 to 24.9 overweight and set obesity at 25. It adds waist cut-offs of 90 cm for men and 80 cm for women.
A doctor weighs those numbers with your health history and your other medicines before deciding whether a GLP-1 medicine suits you at all. Whichever brand you use, the dose plan, the step-ups and the checks belong with a doctor who follows you over months, not with a one-time prescription.
| Conclusion |
| All three brands carry the same GLP-1 medicine, semaglutide; the pen and the distribution behind it are what differ. Noveltreat uses five single-strength prefilled pens, Semaglyn uses one reusable dial-a-dose pen with 15 mg cartridges, and Samakind’s device details should be confirmed from its carton. Dose accuracy depends on the specific device and how you handle it, not on whether the pen is reusable. Switching brands works at the same milligram dose on your usual day, but only through the doctor supervising your treatment. |
Frequently Asked Questions
1. Which Indian semaglutide brand is best?
No brand is better for everyone, because Noveltreat, Semaglyn and Samakind contain the same medicine. They differ in the pen, the strengths on offer and how reliably your local chemist stocks them. The right choice is the brand whose device you can use confidently and buy every month, chosen with a doctor who supervises your dose plan.
2. Do reusable and prefilled pens differ in accuracy?
Not as a category. Pens sold for medical use must meet an international accuracy standard, and laboratory testing has found steady and less steady devices in both groups. In daily use, errors come more often from handling, such as skipping the flow check or lifting the pen before the count ends, so learn your specific pen properly.
3. Are the dose steps identical across brands?
The steps follow the same standard ladder of 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg, rising every four weeks. Noveltreat sells a separate pen for each step, while Semaglyn dials each step from one cartridge. Confirm Samakind’s strengths on its carton, because its launch material did not list them.
4. Which brands are most widely stocked?
No independent public data ranks them on stock. Sun Pharma and Zydus launched nationally in March 2026, and Zydus sells the same product under three names. Mankind has said Samakind will use its network in smaller cities and towns. Your local chemist’s reordering matters more than national reach, so ask before your current pen runs low.
5. Can I switch between brands mid-treatment?
Yes, through your doctor. Because the medicine is identical, a switch usually keeps the same milligram dose and the same weekly injection day. The device changes, so learn the new pen before your first dose, never move medicine between pens, and tell your doctor if nausea or appetite changes in the first two weeks.
| Medical Disclaimer |
| This article is for general education only and is not medical advice. Semaglutide is a prescription-only medicine in India; whether it suits you, which dose you take and how you step up should be decided and monitored by a doctor who knows your health history. Product details reflect manufacturer information available in October 2026 and may change. |